The present invention relates to: a marker for the prognosis of liver cancer; a composition for estimating the prognosis of liver cancer, which contains a substance for detecting a change in the expression level of the prognostic marker for liver cancer; a kit for estimating the prognosis of ...
NOVEL LIVER CANCER MARKERIt becomes possible to diagnose whether or not a patient having a chronic liver disease is affected by liver cancer, by measuring the blood HDGF level in the patient. Also provided is a measurement kit for use in the diagnosis.MURATA, KAORI...
Hepatocellular carcinoma is the fifth most common cancer worlwide. Validated markers for liver cancer will improve early HCC detection.
These markers identified in 2015 could be selected for the HCC curation through blocking them. Su et al., found that expression of known oncomarker of HCC, gankyrin, is promoted by IL-1b/IRAK-1 signaling through JNK and NF-Y/p300/CBP complex. Upregulation of gankirin can be blocked by...
against liver cancer, a deadly yet common cancer. Despite advances in treatments, obstacles persist in early detection and equity in healthcare access. The journey towards improving patient outcomes remains bumpy. Gaining insights from failures is critical for effectively tackling this persistent health ...
Non-B DNA-informed mutation burden as a marker of treatment response and outcome in cancer Qi Xu & Jeanne Kowalski Article 14 October 2024 | Open Access Identification of a 5-gene signature panel for the prediction of prostate cancer progression Michelle Shen , Fernando García-Marqués ...
Liver Canceris the most common malignant tumor of the digestive system. 肝癌是消化系统常见的恶性肿瘤. 互联网 Mr. Brown is said to have died ofliver cancer. 据说布朗先生死于肝癌. 互联网 It has an affirmative role in treating protopathicliver cancer. ...
摘要: A novel cancer marker is provided. A method for detecting cancer using a level of BMCC1 gene expression as an indication is provided, in which the cancer is selected from the group consisting of prostate cancer, lung cancer, gastric cancer, bladder cancer, and uterine cancer....
Specifically, the marker is LINC00511. According to the biological marker, a condition that differential expression of the LINC00511 is related with occurrence and development of the liver cancer is found for the first time; in patients with the liver cancer, expression of the LINC00511 is ...
Home ACTL Immunotherapy Treatment & Prevent News Partnership About Us 简体 繁体 英文 Liver CancerLogin Register Home Online Inquiry QQ Inquiry Contact usACTL ImmunotherapyTreatment & PreventAbout UsLanguage - 中文Coyright © 2017 Shenzhen Immuclin Biomed, Inc. All rights reserved....